Anti-SARS-CoV-2 immunoadhesin remains effective against Omicron and other emerging variants of concern.
Cohen-Dvashi H, Weinstein J, Katz M, Eilon-Ashkenazy M, Mor Y, Shimon A, Achdout H, Tamir H, Israely T, Strobelt R, Shemesh M, Stoler-Barak L, Shulman Z, Paran N, Fleishman SJ, Diskin R.
Cohen-Dvashi H, et al. Among authors: israely t.
iScience. 2022 Oct 21;25(10):105193. doi: 10.1016/j.isci.2022.105193. Epub 2022 Sep 28.
iScience. 2022.
PMID: 36188189
Free PMC article.